Konitsioti, Agni-Maria ORCID: 0000-0002-7296-4349, Laurent, Sarah, Ellenberger, David, Stahmann, Alexander, Rommer, Paulus, Haas, Judith and Warnke, Clemens (2025). MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS Register. Journal of Neurology, 272 (4). pp. 1-9. Springer Nature. ISSN 0340-5354

[thumbnail of s00415-025-13010-6.pdf] PDF
s00415-025-13010-6.pdf
Bereitstellung unter der CC-Lizenz: Creative Commons Attribution.

Download (1MB)
Identification Number:10.1007/s00415-025-13010-6

Abstract

[Artikel-Nr. 294] Background: The COVID-19 pandemic affected healthcare management for people with multiple sclerosis (PwMS), leading to alterations in disease-modifying therapies (DMTs) due to concerns about COVID-19 outcomes and vaccine efficacy. Objectives: To compare DMT prescription patterns in PwMS before, during, and after the COVID-19 pandemic. Methods: PwMS from the German MS Register, between 2019 and 2024, either newly diagnosed (Cohort A) or who discontinued or switched DMT (Cohort B), were analyzed over a follow-up period of 3 months. Data from the pre-pandemic period were compared to early-, late-, and post-pandemic periods. DMTs were categorized as medium efficacy (meDMT) or high efficacy (heDMT). Results: In Cohort A ( n = 1810), pre-pandemic 46% had no DMT within 3 months of diagnosis, 39% received meDMT, and 15% heDMT (7.5% B cell-depleting therapies (BCD)). heDMT use increased during later periods (“early” 19%, “late” 29%, “post” 41%), with a shift toward BCD. In cohort B ( n = 4246), pre-pandemic 47% paused DMT, 19% switched to meDMT, and 34% to heDMT (17% BCD). heDMT use also rose during the pandemic (“early” 37%, “late” 47%, “post” 48%), with increased BCD use. Conclusions: There were no delays in DMT initiation or resumption during the pandemic with a notable increase in heDMT and BCD use, reflecting growing confidence in these treatment options.

Item Type: Article
Creators:
Creators
Email
ORCID
ORCID Put Code
Konitsioti, Agni-Maria
UNSPECIFIED
UNSPECIFIED
Laurent, Sarah
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Ellenberger, David
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Stahmann, Alexander
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Rommer, Paulus
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Haas, Judith
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Warnke, Clemens
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
URN: urn:nbn:de:hbz:38-797870
Identification Number: 10.1007/s00415-025-13010-6
Journal or Publication Title: Journal of Neurology
Volume: 272
Number: 4
Page Range: pp. 1-9
Date: 26 April 2025
Publisher: Springer Nature
ISSN: 0340-5354
Language: English
Faculty: Faculty of Medicine
Divisions: Faculty of Medicine > Neurologie > Klinik und Poliklinik für Neurologie
Subjects: Medical sciences Medicine
['eprint_fieldname_oa_funders' not defined]: Publikationsfonds UzK
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/79787

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item